REPLReplimune Group, Inc.May 22, 2025Q4 2025
Read transcript →Replimune Group, Inc. (REPL) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$12.67
+6.47%
Mkt Cap $940.40M
REPLReplimune Group, Inc.May 22, 2025REPLReplimune Group, Inc.May 22, 2025